PortfoliosLab logoPortfoliosLab logo
Grok 2: Growth ETFs
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


RIGL 10.00%BLND 10.00%TVTX 10.00%ATRA 10.00%OKTA 10.00%TSLA 10.00%CRM 10.00%AMZN 10.00%MSFT 10.00%NRG 10.00%EquityEquity

S&P 500 Index

Portfolio Optimizer

Find the right asset allocation for Grok 2: Growth ETFs

Add portfolio to the optimizer to find optimal allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Grok 2: Growth ETFs, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is never rebalanced.


Loading charts...

Returns By Period


Position1D1MYTD6M1Y3Y*5Y*10Y*
Benchmark
S&P 500 Index
0.30%0.09%8.18%8.17%23.42%19.88%11.91%13.45%
Portfolio
Grok 2: Growth ETFs
0.70%0.30%-8.00%-6.79%15.15%26.38%
AMZN
Amazon.com, Inc
-0.33%-10.07%6.24%8.08%14.82%25.71%8.37%21.19%
ATRA
Atara Biotherapeutics, Inc.
-3.43%14.87%-47.04%-36.47%3.79%-42.16%-51.49%-32.50%
BLND
Blend Labs, Inc.
5.56%23.91%-43.75%-46.89%-54.28%20.39%
CRM
Salesforce, Inc.
-1.68%0.40%-30.92%-29.37%-33.00%-4.89%-4.74%8.51%
MSFT
Microsoft Corporation
-1.18%-0.60%-14.48%-15.77%-11.77%8.85%11.09%24.64%
NRG
NRG Energy, Inc.
-1.15%-7.53%-19.30%-21.70%-17.17%58.56%31.87%26.54%
OKTA
Okta, Inc.
-1.58%39.27%35.13%33.86%11.20%17.84%-11.66%
RIGL
Rigel Pharmaceuticals, Inc.
0.50%15.51%-29.77%-30.69%39.97%23.16%-5.96%2.33%
TSLA
Tesla, Inc.
4.59%-4.53%-9.07%-6.97%38.56%18.72%15.43%39.56%
TVTX
Travere Therapeutics, Inc.
2.77%10.52%23.21%37.30%207.31%41.35%25.91%10.47%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jul 16, 2021, Grok 2: Growth ETFs's average daily return is +0.05%, while the average monthly return is +0.82%. At this rate, an investment would double in approximately 7.1 years.

Historically, 50% of months were positive and 50% were negative. The best month was Nov 2024 with a return of +17.4%, while the worst month was Apr 2022 at -15.1%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 8 months.

On a daily basis, Grok 2: Growth ETFs closed higher 53% of trading days. The best single day was May 12, 2025 with a return of +11.4%, while the worst single day was May 2, 2023 at -8.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-9.52%0.57%-9.92%13.21%3.95%-4.62%-8.00%
20257.65%-6.48%-9.89%8.47%14.09%1.55%3.27%-0.25%8.64%10.54%-0.19%-0.33%40.29%
2024-2.04%7.06%3.31%-5.61%3.60%3.99%1.63%2.02%11.24%0.99%17.38%-3.33%45.62%
202315.29%-1.27%4.82%-4.92%4.04%1.63%5.21%-5.19%-8.57%-5.29%13.17%9.41%28.30%
2022-8.16%-4.83%-1.19%-15.05%-6.89%-4.85%4.39%1.59%-10.02%-3.40%-5.44%-9.43%-48.69%
2021-1.03%10.74%-0.50%9.25%-3.15%-2.25%12.77%

Benchmark Metrics

Grok 2: Growth ETFs has an annualized alpha of -5.74%, beta of 1.40, and R2 of 0.63 versus S&P 500 Index. Calculated based on daily prices since July 16, 2021.

  • This portfolio participated in 118.40% of S&P 500 Index downside but only 101.99% of its upside - more exposed to losses than it benefited from rallies.
  • This portfolio had an annualized alpha of -5.74% versus S&P 500 Index - delivering less than market exposure alone would predict.

Alpha
-5.74%
Beta
1.40
0.63
Upside Capture
101.99%
Downside Capture
118.40%

Expense Ratio

Grok 2: Growth ETFs has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


The portfolio doesn't include any funds that charge management fees.

Return for Risk

Risk / Return Rank

Grok 2: Growth ETFs ranks 9 for risk / return — in the bottom 9% of Portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


Grok 2: Growth ETFs Risk / Return Rank: 99
Overall Rank
Grok 2: Growth ETFs Sharpe Ratio Rank: 99
Sharpe Ratio Rank
Grok 2: Growth ETFs Sortino Ratio Rank: 99
Sortino Ratio Rank
Grok 2: Growth ETFs Omega Ratio Rank: 99
Omega Ratio Rank
Grok 2: Growth ETFs Calmar Ratio Rank: 88
Calmar Ratio Rank
Grok 2: Growth ETFs Martin Ratio Rank: 88
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below presents risk-adjusted performance metrics for Grok 2: Growth ETFs and compares them with S&P 500 Index.


PortfolioBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

0.60

1.94

-1.34

Sortino ratioReturn per unit of downside risk

1.02

2.63

-1.61

Omega ratioGain probability vs. loss probability

1.12

1.35

-0.23

Calmar ratioReturn relative to maximum drawdown

0.65

2.59

-1.94

Martin ratioReturn relative to average drawdown

1.73

11.84

-10.12


How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.

PositionRisk / Return RankSharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
AMZN
Amazon.com, Inc
560.490.891.110.681.64
ATRA
Atara Biotherapeutics, Inc.
510.031.211.190.050.09
BLND
Blend Labs, Inc.
12-0.76-0.970.88-0.80-1.33
CRM
Salesforce, Inc.
8-0.88-1.170.86-0.84-1.62
MSFT
Microsoft Corporation
24-0.47-0.490.94-0.35-0.73
NRG
NRG Energy, Inc.
22-0.39-0.270.97-0.53-1.31
OKTA
Okta, Inc.
500.210.771.100.300.71
RIGL
Rigel Pharmaceuticals, Inc.
610.581.401.170.801.41
TSLA
Tesla, Inc.
660.871.431.171.293.01
TVTX
Travere Therapeutics, Inc.
942.923.861.486.2314.39

Sharpe Ratio

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Grok 2: Growth ETFs Sharpe ratios as of Jun 9, 2026 (values are recalculated daily):

  • 1-Year: 0.60
  • All Time: 0.23

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 1.60 to 2.46, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of Grok 2: Growth ETFs compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading charts...

Dividends

Dividend yield

Grok 2: Growth ETFs provided a 0.32% dividend yield over the last twelve months.


PositionTTM20252024202320222021202020192018201720162015
Portfolio0.32%0.24%0.30%0.37%0.55%0.37%0.41%0.15%0.20%0.23%0.43%0.73%
AMZN
Amazon.com, Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ATRA
Atara Biotherapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
BLND
Blend Labs, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
CRM
Salesforce, Inc.
0.92%0.63%0.48%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
MSFT
Microsoft Corporation
0.86%0.70%0.73%0.74%1.06%0.68%0.94%1.20%1.69%1.86%2.37%2.33%
NRG
NRG Energy, Inc.
1.43%1.11%1.81%2.92%4.40%3.02%3.20%0.30%0.30%0.42%1.92%4.93%
OKTA
Okta, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
RIGL
Rigel Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TSLA
Tesla, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TVTX
Travere Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Grok 2: Growth ETFs. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Grok 2: Growth ETFs was 56.58%, occurring on Dec 27, 2022. Recovery took 595 trading sessions.

The current Grok 2: Growth ETFs drawdown is 10.51%.


Related event

Drawdown

Fall

Recovery

Underwater

Bear market2022
-56.58%Dec 2022
1y 1mo2y 4mo
3y 6moNov 2021 - May 2025
2026 bear market2026
-23.51%Mar 2026
3mo 4d
5mo 15dDec 2025 - now
2025 selloff2025
-6.61%Jun 2025
1mo 2d1mo 14d
2mo 16dMay 2025 - Jul 2025
2025 pullback2025
-6.30%Nov 2025
16d1mo 4d
1mo 20dNov 2025 - Dec 2025
2025 pullback2025
-5.05%Oct 2025
17d14d
1mo 1dSep 2025 - Oct 2025

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Diversification

Diversification Metrics


Number of Effective Assets

The portfolio contains 10 assets, with an effective number of assets of 10.00, reflecting the diversification based on asset allocation. Your capital is spread almost evenly across your holdings, indicating a well-balanced allocation. Note that true diversification also depends on the correlations between assets — check the diversification ratio below.


Diversification Ratio
1Y
3Y
All Time
Diversification Ratio

2.09

1.89

1.79

The portfolio has a diversification ratio of 1.79, in line with the typical range across portfolios. There's room to improve by adding less correlated assets.

Grok 2: Growth ETFs correlation to the S&P 500 Index

Grok 2: Growth ETFs has a 0.66 correlation to S&P 500 Index over the trailing 12 months. This section compares each holding's correlation to the benchmark and to the portfolio.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.66

Correlation (3Y)
Calculated over the trailing 3-year period

0.76

Correlation (All Time)
Calculated using the full available price history since Jul 16, 2021

0.77


Benchmark Correlations

Correlation vs. S&P 500 Index. MSFT has the highest benchmark correlation at 0.73, while RIGL has the lowest at 0.32.

RIGL
0.32
ATRA
0.34
TVTX
0.36
BLND
0.36
NRG
0.47
OKTA
0.52
TSLA
0.58
CRM
0.58
AMZN
0.70
MSFT
0.73

Portfolio Correlations

Correlation vs. Grok 2: Growth ETFs. TSLA has the highest portfolio correlation at 0.65, while ATRA has the lowest at 0.43.

ATRA
0.43
BLND
0.44
RIGL
0.49
OKTA
0.55
NRG
0.56
CRM
0.59
TVTX
0.61
MSFT
0.62
AMZN
0.63
TSLA
0.65

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

The correlation results are calculated based on daily price changes starting from Jul 16, 2021
Diversification Analysis

Find what Grok 2: Growth ETFs is missing

See which holdings overlap, where Grok 2: Growth ETFs is concentrated, and which low-correlation assets could fill the gaps.

Analyze Diversification